Search Results - "Cherrington, J.M"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus by Garcia-Soria, G, Gonzalez-Galvez, G, Argoud, G.M, Gerstman, M, Littlejohn, T.W. III, Schwartz, S.L, O'Farrell, A.-M, Li, X, Cherrington, J.M, Bennett, C, Guler, H.-P

    Published in Diabetes, obesity & metabolism (01-04-2008)
    “…To determine the efficacy and tolerability of PHX1149, a novel dipeptidyl peptidase-4 (DPP4) inhibitor, in patients with type 2 diabetes. This is a…”
    Get full text
    Journal Article
  2. 2

    NF‐kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation by Sambucetti, L.C., Cherrington, J.M., Wilkinson, G.W., Mocarski, E.S.

    Published in The EMBO journal (20-12-1989)
    “…The expression of cytomegalovirus alpha (immediate early) genes is under control of an enhancer that carries signals for strong constitutive expression as well…”
    Get full text
    Journal Article
  3. 3

    Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses by Mulato, A.S, Cherrington, J.M

    Published in Antiviral research (01-11-1997)
    “…Adefovir (PMEA, 9-(2-phosphonomethoxyethyl)adenine), an acyclic nucleoside phosphonate analogue is active against retroviruses, hepadnaviruses and…”
    Get full text
    Journal Article
  4. 4

    Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy by Bowen, E.F., Cherrington, J.M., Lamy, P.D., Griffiths, P.D., Johnson, M.A., Emery, V.C.

    Published in Journal of medical virology (01-08-1999)
    “…Five AIDS patients with cytomegalovirus (CMV) retinitis who had received ganciclovir (GCV) therapy were followed with serial blood sampling to detectchanges…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Virological, clinical and serological responses of sheep infected with tissue culture adapted bluetongue virus serotypes 10, 11, 13 and 17 by Ghalib, H W, Cherrington, J M, Osburn, B I

    Published in Veterinary microbiology (01-01-1985)
    “…Sheep were experimentally infected with cloned strains of tissue culture adapted bluetongue virus (BTV) serotypes 10, 11, 13 and 17. All the infected animals…”
    Get more information
    Journal Article